Interferon Alpha: all 55 studies that test it
Page 1 of 1. Open to participants first (1), then studies with results posted, then the rest; newest registration first within each.
- Sequential PEG-IFN for HBV After Ending RNA-targeted RegimensRecruitingNCT06923280Not applicable
- Short Term Treatment With BI 201335, Peginterferon-alpha 2a and Ribavirin in Hepatitis c Virus Genotype-1 Treatment-naïve Patients (SILEN-C3)CompletedNCT00984620Phase 2Results posted
- Thymosin Alpha 1, Interferon Alpha, or Both, in Combination With Dacarbazine in Patients With Malignant MelanomaCompletedNCT00911443Phase 2Results posted
- Interferon Alpha Lozenges in the Prevention of Winter Colds and FluCompletedNCT00895947Phase 2Results posted
- Interferon-alpha Lozenges for Prevention of Relapse in Hepatitis CCompletedNCT00695019Phase 2Results posted
- Treatment of Oral Warts in HIV+ PatientsCompletedNCT00454181Phase 2Results posted
- Chemoradiation in Locally Advanced Pancreatic CancerTerminatedNCT00262951Phase 2Results posted
- Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic CancerCompletedNCT00068575Phase 2Results posted
- Study Evaluating Interferon And CCI-779 In Advanced Renal Cell CarcinomaCompletedNCT00065468Phase 3Results posted
- Interferon Alfa, Isotretinoin, and Paclitaxel in Treating Patients With Recurrent Small Cell Lung CancerCompletedNCT00062010Phase 2Results posted
- Tretinoin Plus Interferon Alfa in Treating Patients With Metastatic Kidney CancerCompletedNCT00003656Phase 2Results posted
- Adjuvant Therapy of Skin Melanoma With Alpha Interferon and NaderinCompletedNCT07671495Phase 2
- COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;CompletedNCT04534725Phase 3
- Interferon-α Prevents Leukemia Relapse of AML Patients After TransplantationWithdrawnNCT03121079Not applicable
- Treatment of Follicular Lymphoma With High Dose Therapy and Stem Cell Support Followed by Rituximab and Alpha InterferonCompletedNCT03069248Phase 2
- Pharmaco-immunological Study of Interferon-alpha and Metronomic Cyclophosphamide Association in Neuroendocrine TumorsCompletedNCT02838342Phase 2
- Interferon for the Intervention of Molecular Relapse in t (8; 21) AML After Allo-HSCTStatus unknownNCT02027064Phase 4
- Adjuvant IFN-α for Patients Underwent Curative Surgery for HCC With a Low miR-26 ExpressionStatus unknownNCT01681446Phase 3
- Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health OutcomesWithdrawnNCT01625793Not applicable
- Determining the Maximum Tolerated Dose of Low Dose Interferon-alpha in Conjunction With Nilotinib in Pretreated Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia Patients in Chronic Phase (CML-CP)CompletedNCT01220648Phase 1
- Granulocyte-macrophage Colony-stimulating Factor, Interferon and Interleukin-2 as Adjuvant Treatment for Renal CancerCompletedNCT01176552Phase 2
- Interferon Alpha Lozenges Plus Oseltamivir for Influenza TreatmentCompletedNCT01146535Phase 2
- Modulation of Adjuvant 5-FU by Folinic Acid and Interferon-alpha in Colon CancerCompletedNCT01060501Phase 3
- Interactions of Hepatitis C Viral (HCV) Dynamics and Immune Activation in HIV Coinfected Patients During HCV TreatmentCompletedNCT00909129Not applicable
- The Efficiency of Postoperative Interferon-alpha Treatment in p48 Positive Patients With Hepatocellular CarcinomaWithdrawnNCT00838968Not applicable
- NIDDM and IR in Combination Therapy for CHCCompletedNCT00687999Not applicable
- Chemotherapy and Radiation Following Pancreatic SurgeryCompletedNCT00660270Phase 2
- Capecitabine and Interferon-Alpha in Metastatic Renal Cell Carcinoma Patients With Failure on Interleukin-2 Based RegimensCompletedNCT00591188Phase 2
- Intron-A/Aldara Combination Therapy for Basal Cell Carcinoma (BCC)CompletedNCT00581425Phase 4
- Recombinant Interferon Alpha and Etoposide in Relapsed OsteosarcomaCompletedNCT00504140Phase 2
- High-Dose Interferon Alfa in Treating Patients With Stage II or StageIII MelanomaWithdrawnNCT00447356Phase 3
- Safety Study of TroVax Alone vs. TroVax Plus Interferon Alpha in Patients With Renal CancerCompletedNCT00445523Phase 2
- Combined Use of BCG and Interferon Alpha in Bladder CancerCompletedNCT00330707Phase 2/3
- Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic CancerCompletedNCT00329368Phase 1
- Interferon-Induced Gene Expression in Liver Cells and Peripheral Blood LymphocytesCompletedNCT00324389Phase 2
- Virotherapy and Natural History Study of KHSV-Associated Multricentric Castleman s Disease With Correlates of Disease ActivityActive, not recruitingNCT00092222Phase 2
- Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the UrotheliumCompletedNCT00082719Phase 1
- Oblimersen and Interferon Alfa in Treating Patients With Metastatic Renal Cell CancerCompletedNCT00059813Phase 2
- Phase II Study Of Roferon and Accutane For Patients With T-Cell MalignanciesCompletedNCT00038376Phase 2
- Ingested Interferon Alpha: Prolongation or Permanence of the "Honeymoon" Phase in Newly Diagnosed Type 1 Diabetes MellitusStatus unknownNCT00005665Phase 2
- Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-AlfaCompletedNCT00005615Phase 1/2
- Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis CCompletedNCT00004804Phase 3
- Interferon Alfa-2b in Treating Patients With Melanoma and Early Lymph Node MetastasisCompletedNCT00004196Phase 3
- Interferon Alfa-2b Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory Hodgkin's Disease or Non-Hodgkin's LymphomaStatus unknownNCT00003924Phase 3
- Interferon Alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the GroinCompletedNCT00003444Phase 3
- Interferon Alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant MeningiomasCompletedNCT00002965Phase 2
- Interferon Alfa or No Further Therapy Following Surgery in Treating Patients With Stage II, Stage III, or Recurrent MelanomaCompletedNCT00002892Phase 3
- S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic AmyloidosisCompletedNCT00002849Phase 2
- Combination Chemotherapy in Treating Patients With LymphomaCompletedNCT00002835Phase 3
- Bone Marrow Transplantation in Treating Patients With LymphomaCompletedNCT00002829Phase 2
- High-Dose or Low-Dose Interferon Alfa Compared With No Further Therapy Following Surgery in Treating Patients With Stage III MelanomaStatus unknownNCT00002763Phase 3
- SWOG-9239 Reduction of Immunosuppression Plus Interferon Alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ TransplantCompletedNCT00002657Phase 2
- Interferon Alfa in Treating Children With HIV-Related CancerCompletedNCT00002621Phase 2
- Homoharringtonine and Interferon Alfa in Treating Patients With Chronic Myelogenous LeukemiaCompletedNCT00002574Phase 2
- A Phase II Trial of All-Trans-Retinoic Acid in Combination With Interferon-Alpha 2a in Children With Recurrent Neuroblastoma or Wilms' TumorCompletedNCT00001509Phase 2